Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-02T23:28:58.905Z Has data issue: false hasContentIssue false

P02.271 Pharmacokinetic drug interaction potential of risperidone as assessed by the dextromethorphan, the caffeine and the mephenytoin test

Published online by Cambridge University Press:  16 April 2020

C.B. Eap
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
G. Bondolfi
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
D. Zullino
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
C. Bryois
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
M. Fuciec
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
L. Savary
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
M. Jonzier-Perey
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland
P. Baumann
Affiliation:
University Department of Adult Psychiatry, CH-10008Prilly-Lausanne, Switzerland

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Copyright
Copyright © European Psychiatric Association 2000

References

Koreen, ARet al., Am J Psychiatry 1995; 152 S2: 169010.1176/ajp.152.11.1690aCrossRefGoogle Scholar
Tyson, SCet al., Am J Psychiatry 1995: 152 S2: 1401–210.1176/ajp.152.9.1401aCrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.